EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Promise of Emergent Nanobiotechnologies for In Vivo Applications and Implications for Safety and Security

Anne M Arnold, Ashley M Bradley, Karen L Taylor, Zachary C Kennedy, Kristin M Omberg

Health Security · 01.10.2022 · 20 (5) · 408-423

DOI: 10.1089/hs.2022.0014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Security, online erschienen am 17.10.2022. Verfasst von Anne M Arnold und 4 weiteren Autor:innen. Beteiligte Einrichtung: Anne M. Arnold, PhD, is a Materials Scientist, National Security Directorate, Pacific Northwest National Laboratory, Richland, WA. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 194 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanotechnology, the multidisciplinary field based on the exploitation of the unique physicochemical properties of nanoparticles (NPs) and nanoscale materials, has opened a new realm of possibilities for biological research and biomedical applications. The development and deployment of mRNA-NP vaccines for COVID-19, for example, may revolutionize vaccines and therapeutics. However, regulatory and ethical frameworks that protect the health and safety of the global community and environment are lagging, particularly for nanotechnology geared toward biological applications (ie, bionanotechnology). In this article, while not comprehensive, we attempt to illustrate the breadth and promise of bionanotechnology developments, and how they may present future safety and security challenges. Specifically, we address current advancements to streamline the development of engineered NPs for in vivo applications and provide discussion on nano–bio interactions, NP in vivo delivery, nanoenhancement of human performance, nanomedicine, and the impacts of NPs on human health and the environment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19HumansNanomedicineNanotechnologyRNA, Messenger

Stichwörter der Autor:innen

Biosafety protectionBiotech industryCode of conductDual-use scienceNanoparticles

Substanzen

COVID-19 VaccinesRNA, Messenger

Autor:innen und Institutionen

  • Anne M. Arnold, PhD, is a Materials Scientist, National Security Directorate, Pacific Northwest National Laboratory, Richland, WA.
  • Ashley M. Bradley is a Biomedical Scientist, National Security Directorate, Pacific Northwest National Laboratory, Richland, WA.
  • Karen L. Taylor, MPH, is a Senior Technical Advisor, National Security Directorate, Pacific Northwest National Laboratory, Seattle, WA.
  • Zachary C. Kennedy, PhD, is a Materials Scientist, National Security Directorate, Pacific Northwest National Laboratory, Richland, WA.
  • Kristin M. Omberg, PhD, is Group Leader, National Security Directorate, Pacific Northwest National Laboratory, Richland, WA.

Zitieren

APA

Arnold, A. M., Bradley, A. M., Taylor, K. L., Kennedy, Z. C., & Omberg, K. M. (2022). The Promise of Emergent Nanobiotechnologies for In Vivo Applications and Implications for Safety and Security. Health Security, 20(5), 408-423. https://doi.org/10.1089/hs.2022.0014

Vancouver

Arnold AM, Bradley AM, Taylor KL, Kennedy ZC, Omberg KM. The Promise of Emergent Nanobiotechnologies for In Vivo Applications and Implications for Safety and Security. Health Security. 2022;20(5):408-423. doi:10.1089/hs.2022.0014

BibTeX
@article{Arnold2022,
  author = {Arnold, Anne M and Bradley, Ashley M and Taylor, Karen L and Kennedy, Zachary C and Omberg, Kristin M},
  title = {The Promise of Emergent Nanobiotechnologies for In Vivo Applications and Implications for Safety and Security},
  journal = {Health Security},
  year = {2022},
  volume = {20},
  number = {5},
  pages = {408--423},
  doi = {10.1089/hs.2022.0014}
}
Kostenlos starten →